Laborate Pharmaceutical (India)
⚠️ High Risk
FEI: 3010875009 • Paonta Sahib, Himachal Pradesh • INDIA
FEI Number
3010875009
Location
Paonta Sahib, Himachal Pradesh
Country
INDIAAddress
31 Rajban Road, , Paonta Sahib, Himachal Pradesh, India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 3/26/2025 | 56BDA99SYNTHETIC PENICILLIN, N.E.C. | Division of Southeast Imports (DSEI) | |
| 1/26/2024 | 64HDY01BROMHEXINE HCL (EXPECTORANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/20/2021 | 54YFK99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is Laborate Pharmaceutical (India)'s FDA import refusal history?
Laborate Pharmaceutical (India) (FEI: 3010875009) has 3 FDA import refusal record(s) in our database, spanning from 12/20/2021 to 3/26/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laborate Pharmaceutical (India)'s FEI number is 3010875009.
What types of violations has Laborate Pharmaceutical (India) received?
Laborate Pharmaceutical (India) has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Laborate Pharmaceutical (India) come from?
All FDA import refusal data for Laborate Pharmaceutical (India) is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.